Investor Eye: Novalis Embraces Early Investment And Enabling Technology
Novalis Biotech employs early targeted investments to produce returns, focusing on enabling technologies and risky ventures in diagnostics and digital health.
You may also be interested in...
In an interview with Medtech Insight, Octopus Ventures partner Pooja Sikka explained the approach Octopus takes to investments, and the key challenges the fund wants to address.
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.